Innoviva (INVA) Interest & Investment Income (2010 - 2021)
Innoviva posted quarterly Interest & Investment Income of $453000.0 for Q3 2021, up 1004.88% year-on-year from $41000.0 in Q3 2020, and up 2165.0% on a QoQ basis from $20000.0 in Q2 2021.
Innoviva (INVA) has 12 years of Interest & Investment Income data on file, last reported at $453000.0 in Q3 2021.
- For the quarter ending Q3 2021, Interest & Investment Income rose 1004.88% year-over-year to $453000.0; the trailing twelve-month figure through Sep 2021 stood at $526000.0 (down 82.69% YoY), and the FY2020 full-year result was $1.5 million, down 72.49% from the prior year.
- Interest & Investment Income for Q3 2021 stood at $453000.0, up from $20000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.6 million in Q3 2019 and bottomed at $20000.0 in Q2 2021.
- The 5-year median for Interest & Investment Income is $380000.0 (2018), against an average of $554631.6.
- The widest annual swing landed in 2020, when Interest & Investment Income plunged 98.5%; it then surged 1004.88% in 2021.
- A 5-year view of Interest & Investment Income shows it stood at $393000.0 in 2017, then surged by 32.06% to $519000.0 in 2018, then surged by 196.34% to $1.5 million in 2019, then slumped by 98.5% to $23000.0 in 2020, then jumped by 1869.57% to $453000.0 in 2021.
- The last three Interest & Investment Income figures came in at $453000.0 (Q3 2021), $20000.0 (Q2 2021), and $30000.0 (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 453,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | 30,000.00 |
| Dec 31, 2020 | 23,000.00 |
| Sep 30, 2020 | 41,000.00 |
| Jun 30, 2020 | 158,000.00 |
| Mar 31, 2020 | 1.30 Mn |
| Dec 31, 2019 | 1.54 Mn |
| Sep 30, 2019 | 1.62 Mn |
| Jun 30, 2019 | 1.40 Mn |
| Mar 31, 2019 | 975,000.00 |
| Dec 31, 2018 | 519,000.00 |
| Sep 30, 2018 | 370,000.00 |
| Jun 30, 2018 | 380,000.00 |
| Mar 31, 2018 | 391,000.00 |
| Dec 31, 2017 | 393,000.00 |
| Sep 30, 2017 | 376,000.00 |
| Jun 30, 2017 | 306,000.00 |
| Mar 31, 2017 | 236,000.00 |
| Dec 31, 2016 | 171,000.00 |
| Sep 30, 2016 | 162,000.00 |
| Jun 30, 2016 | 157,000.00 |
| Mar 31, 2016 | 92,000.00 |
| Dec 31, 2015 | 52,000.00 |
| Sep 30, 2015 | 90,000.00 |
| Jun 30, 2015 | 85,000.00 |
| Mar 31, 2015 | 116,000.00 |
| Dec 31, 2014 | 117,000.00 |
| Sep 30, 2014 | 93,000.00 |
| Jun 30, 2014 | 165,000.00 |
| Mar 31, 2014 | 188,000.00 |
| Dec 31, 2013 | 211,000.00 |
| Sep 30, 2013 | 192,000.00 |
| Jun 30, 2013 | 190,000.00 |
| Mar 31, 2013 | 185,000.00 |
| Dec 31, 2012 | 156,000.00 |
| Sep 30, 2012 | 158,000.00 |
| Jun 30, 2012 | 90,000.00 |
| Mar 31, 2012 | 56,000.00 |
| Dec 31, 2011 | 71,000.00 |
| Sep 30, 2011 | 81,000.00 |
| Jun 30, 2011 | 118,000.00 |
| Sep 30, 2010 | 136,000.00 |
| Jun 30, 2010 | 134,000.00 |